Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 76,436 | 22,881 | 150,245 | 65,871 | 43,857 |
| Cost of Goods | 5,291 | 7,203 | 965 | N/A | N/A |
| Gross Profit | 71,145 | 15,678 | 149,280 | 65,871 | 43,857 |
| Operating Expenses | 240,806 | 267,883 | 223,007 | 132,013 | 104,623 |
| Operating Income | -169,370 | -252,002 | -72,762 | -66,142 | -60,766 |
| Interest Expense | 21,166 | 21,002 | 59 | 63 | 196 |
| Other Income | 918 | 192 | 197 | 1,356 | 1,607 |
| Pre-tax Income | -189,618 | -272,812 | -72,624 | -64,849 | -59,355 |
| Income Tax | N/A | N/A | N/A | 3 | -2,944 |
| Net Income Continuous | -189,618 | -272,812 | -72,624 | -64,852 | -56,411 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 4,551 |
| Minority Interests | N/A | N/A | N/A | N/A | 1,121 |
| Net Income | $-189,618 | $-272,812 | $-72,624 | $-64,852 | $-52,981 |
| EPS Basic Total Ops | -1.39 | -2.35 | -0.68 | -0.65 | -0.59 |
| EPS Basic Continuous Ops | -1.39 | -2.35 | -0.68 | -0.65 | -0.63 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.04 |
| EPS Diluted Total Ops | -1.39 | -2.35 | -0.68 | -0.65 | -0.59 |
| EPS Diluted Continuous Ops | -1.39 | -2.35 | -0.68 | -0.65 | -0.63 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.04 |
| EBITDA(a) | $-157,039 | $-240,273 | $-61,437 | $-56,143 | $-54,605 |